The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population
Copyright © 2017 American Society for Microbiology..
We studied in parallel the population structure of 90 carbapenemase-producing and 88 carbapenemase-susceptible Klebsiella pneumoniae isolates collected in 20 Spanish hospitals, in the context of the EuSCAPE project. Fourteen and 50 multilocus sequence types (MLSTs) were detected among the carbapenemase-producing and carbapenem-susceptible isolates, respectively. ST11 and ST15 clones were more frequent in the carbapenemase-producing group than in the carbapenemase-susceptible group (P < 0.0001). Among the members of the carbapenem-suceptible group, the cefotaxime-resistant population showed population parameters that differed between the populations of the wild-type strains and the carbapenemase producers.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Antimicrobial agents and chemotherapy - 61(2017), 4 vom: 30. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Esteban-Cantos, Andrés [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.09.2017 Date Revised 09.12.2020 published: Electronic-Print Citation Status MEDLINE |
---|
doi: |
10.1128/AAC.02520-16 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM268474982 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM268474982 | ||
003 | DE-627 | ||
005 | 20231224222722.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/AAC.02520-16 |2 doi | |
028 | 5 | 2 | |a pubmed24n0894.xml |
035 | |a (DE-627)NLM268474982 | ||
035 | |a (NLM)28137818 | ||
035 | |a (PII)e02520-16 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Esteban-Cantos, Andrés |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.09.2017 | ||
500 | |a Date Revised 09.12.2020 | ||
500 | |a published: Electronic-Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2017 American Society for Microbiology. | ||
520 | |a We studied in parallel the population structure of 90 carbapenemase-producing and 88 carbapenemase-susceptible Klebsiella pneumoniae isolates collected in 20 Spanish hospitals, in the context of the EuSCAPE project. Fourteen and 50 multilocus sequence types (MLSTs) were detected among the carbapenemase-producing and carbapenem-susceptible isolates, respectively. ST11 and ST15 clones were more frequent in the carbapenemase-producing group than in the carbapenemase-susceptible group (P < 0.0001). Among the members of the carbapenem-suceptible group, the cefotaxime-resistant population showed population parameters that differed between the populations of the wild-type strains and the carbapenemase producers | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Klebsiella pneumoniae | |
650 | 4 | |a MLST | |
650 | 4 | |a carbapenem resistance | |
650 | 4 | |a carbapenemases | |
650 | 4 | |a population structure | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Bacterial Proteins |2 NLM | |
650 | 7 | |a Carbapenems |2 NLM | |
650 | 7 | |a beta-Lactamases |2 NLM | |
650 | 7 | |a EC 3.5.2.6 |2 NLM | |
650 | 7 | |a carbapenemase |2 NLM | |
650 | 7 | |a EC 3.5.2.6 |2 NLM | |
650 | 7 | |a Cefotaxime |2 NLM | |
650 | 7 | |a N2GI8B1GK7 |2 NLM | |
700 | 1 | |a Aracil, Belén |e verfasserin |4 aut | |
700 | 1 | |a Bautista, Verónica |e verfasserin |4 aut | |
700 | 1 | |a Ortega, Adriana |e verfasserin |4 aut | |
700 | 1 | |a Lara, Noelia |e verfasserin |4 aut | |
700 | 1 | |a Saez, David |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Romero, Sara |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Vázquez, María |e verfasserin |4 aut | |
700 | 1 | |a Navarro, Ferran |e verfasserin |4 aut | |
700 | 1 | |a Grundmann, Hajo |e verfasserin |4 aut | |
700 | 1 | |a Campos, José |e verfasserin |4 aut | |
700 | 1 | |a Oteo, Jesús |e verfasserin |4 aut | |
700 | 0 | |a EuSCAPE-Spain Network |e verfasserin |4 aut | |
700 | 1 | |a Alarcón, Teresa |e investigator |4 oth | |
700 | 1 | |a Barba, Isabel |e investigator |4 oth | |
700 | 1 | |a Cercenado, Emilia |e investigator |4 oth | |
700 | 1 | |a de Miguel, M. Antonia |e investigator |4 oth | |
700 | 1 | |a Fontanals, Dionisia |e investigator |4 oth | |
700 | 1 | |a Fleites, Ana M. |e investigator |4 oth | |
700 | 1 | |a Sánchez-Romero, Isabel |e investigator |4 oth | |
700 | 1 | |a Solís, Sonia |e investigator |4 oth | |
700 | 1 | |a Gimeno, Adelina |e investigator |4 oth | |
700 | 1 | |a Hernández, Juan Manuel |e investigator |4 oth | |
700 | 1 | |a Martínez-López, Jesús |e investigator |4 oth | |
700 | 1 | |a Navarro, Ferran |e investigator |4 oth | |
700 | 1 | |a Alós, Juan Ignacio |e investigator |4 oth | |
700 | 1 | |a Arias, Marta |e investigator |4 oth | |
700 | 1 | |a Yagüe, Genoveva |e investigator |4 oth | |
700 | 1 | |a Sainz de Baranda, Caridad |e investigator |4 oth | |
700 | 1 | |a Cordón, Luz Albina |e investigator |4 oth | |
700 | 1 | |a Leiva, José |e investigator |4 oth | |
700 | 1 | |a Pérez-Moreno, Mar Olga |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d 1972 |g 61(2017), 4 vom: 30. Apr. |w (DE-627)NLM000026506 |x 1098-6596 |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2017 |g number:4 |g day:30 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/AAC.02520-16 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2017 |e 4 |b 30 |c 04 |